Ameritas Investment Partners’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $273K | Sell |
1,262
-74
| -6% | -$14.2K | 0.01% | 1209 |
|
|
2026
Q1 | $245K | Hold |
1,336
| – | – | 0.01% | 1148 |
|
|
2025
Q4 | $235K | Sell |
1,336
-4,890
| -79% | -$799K | 0.01% | 1156 |
|
|
2025
Q3 | $872K | Buy |
6,226
+39
| +0.6% | +$5.27K | 0.03% | 655 |
|
|
2025
Q2 | $777K | Hold |
6,187
| – | – | 0.02% | 690 |
|
|
2025
Q1 | $847K | Buy |
6,187
+131
| +2% | +$18.7K | 0.03% | 652 |
|
|
2024
Q4 | $926K | Buy |
6,056
+141
| +2% | +$23.8K | 0.03% | 638 |
|
|
2024
Q3 | $1.15M | Buy |
5,915
+155
| +3% | +$32.4K | 0.04% | 578 |
|
|
2024
Q2 | $1.34M | Sell |
5,760
-53
| -0.9% | -$11.5K | 0.05% | 494 |
|
|
2024
Q1 | $1.25M | Hold |
5,813
| – | – | 0.04% | 540 |
|
|
2023
Q4 | $1.5M | Buy |
5,813
+132
| +2% | +$32.4K | 0.06% | 435 |
|
|
2023
Q3 | $1.46M | Buy |
5,681
+802
| +16% | +$215K | 0.06% | 395 |
|
|
2023
Q2 | $1.39M | Buy |
4,879
+46
| +1% | +$13.7K | 0.05% | 448 |
|
|
2023
Q1 | $1.34M | Buy |
4,833
+34
| +0.7% | +$9.41K | 0.05% | 457 |
|
|
2022
Q4 | $1.4M | Sell |
4,799
-243
| -5% | -$68.6K | 0.06% | 446 |
|
|
2022
Q3 | $1.35M | Hold |
5,042
| – | – | 0.06% | 393 |
|
|
2022
Q2 | $1.03M | Sell |
5,042
-93
| -2% | -$19K | 0.04% | 520 |
|
|
2022
Q1 | $1.08M | Hold |
5,135
| – | – | 0.04% | 594 |
|
|
2021
Q4 | $1.23M | Sell |
5,135
-87
| -2% | -$22.4K | 0.04% | 549 |
|
|
2021
Q3 | $1.48M | Sell |
5,222
-32
| -0.6% | -$10.5K | 0.05% | 422 |
|
|
2021
Q2 | $1.82M | Sell |
5,254
-51
| -1% | -$15.4K | 0.07% | 346 |
|
|
2021
Q1 | $1.48M | Sell |
5,305
-131
| -2% | -$35.3K | 0.06% | 411 |
|
|
2020
Q4 | $1.33M | Sell |
5,436
-23
| -0.4% | -$5.93K | 0.06% | 417 |
|
|
2020
Q3 | $1.55M | Sell |
5,459
-403
| -7% | -$112K | 0.07% | 298 |
|
|
2020
Q2 | $1.57M | Sell |
5,862
-678
| -10% | -$204K | 0.07% | 286 |
|
|
2020
Q1 | $2.07M | Sell |
6,540
-67
| -1% | -$20.3K | 0.12% | 166 |
|
|
2019
Q4 | $1.96M | Buy |
6,607
+28
| +0.4% | +$7.77K | 0.09% | 253 |
|
|
2019
Q3 | $1.53M | Sell |
6,579
-461
| -7% | -$107K | 0.07% | 325 |
|
|
2019
Q2 | $1.65M | Sell |
7,040
-6,973
| -50% | -$1.61M | 0.07% | 298 |
|
|
2019
Q1 | $3.31M | Sell |
14,013
-375
| -3% | -$118K | 0.15% | 106 |
|
|
2018
Q4 | $4.33M | Buy |
14,388
+359
| +3% | +$115K | 0.24% | 63 |
|
|
2018
Q3 | $4.96M | Sell |
14,029
-674
| -5% | -$232K | 0.23% | 60 |
|
|
2018
Q2 | $4.27M | Sell |
14,703
-343
| -2% | -$96.4K | 0.21% | 74 |
|
|
2018
Q1 | $4.12M | Sell |
15,046
-1,670
| -10% | -$518K | 0.2% | 77 |
|
|
2017
Q4 | $5.86M | Sell |
16,716
-1,466
| -8% | -$470K | 0.27% | 53 |
|
|
2017
Q3 | $5.72M | Sell |
18,182
-115
| -0.6% | -$34.1K | 0.27% | 51 |
|
|
2017
Q2 | $4.96M | Sell |
18,297
-365
| -2% | -$96.5K | 0.24% | 58 |
|
|
2017
Q1 | $5.1M | Sell |
18,662
-999
| -5% | -$282K | 0.25% | 54 |
|
|
2016
Q4 | $5.58M | Buy |
19,661
+2,178
| +12% | +$646K | 0.28% | 53 |
|
|
2016
Q3 | $5.47M | Sell |
17,483
-3,609
| -17% | -$1.07M | 0.3% | 43 |
|
|
2016
Q2 | $5.1M | Buy |
21,092
+533
| +3% | +$140K | 0.33% | 52 |
|
|
2016
Q1 | $5.35M | Buy |
20,559
+269
| +1% | +$71.1K | 0.36% | 45 |
|
|
2015
Q4 | $6.21M | Sell |
20,290
-283
| -1% | -$81.3K | 0.42% | 38 |
|
|
2015
Q3 | $6M | Buy |
20,573
+163
| +0.8% | +$53.8K | 0.43% | 34 |
|
|
2015
Q2 | $8.24M | Buy |
20,410
+392
| +2% | +$157K | 0.54% | 21 |
|
|
2015
Q1 | $8.45M | Sell |
20,018
-912
| -4% | -$359K | 0.55% | 24 |
|
|
2014
Q4 | $7.1M | Buy |
20,930
+1,931
| +10% | +$625K | 0.49% | 31 |
|
|
2014
Q3 | $6.29M | Sell |
18,999
-479
| -2% | -$158K | 0.45% | 33 |
|
|
2014
Q2 | $6.14M | Sell |
19,478
-313
| -2% | -$94.2K | 0.44% | 33 |
|
|
2014
Q1 | $6.05M | Buy |
19,791
+3,858
| +24% | +$1.22M | 0.48% | 37 |
|
|
2013
Q4 | $4.46M | Buy |
15,933
+4,486
| +39% | +$1.16M | 0.35% | 54 |
|
|
2013
Q3 | $2.75M | Buy |
11,447
+5,847
| +104% | +$1.31M | 0.26% | 79 |
|
|
2013
Q2 | $1.21M | Buy |
+5,600
| New | +$1.2M | 0.33% | 133 |
|
Other funds holding BIIB
Ameritas Investment Partners's BIIB Position: Q2 2026 in Review
Ameritas Investment Partners reduced its Biogen (BIIB) stake by 5.5% in Q2 2026, selling an estimated $14.2K and leaving 1,262 shares worth $273K. The position accounts for 0.01% of the portfolio, ranked #1209.
Ameritas Investment Partners first reported a position in BIIB in Q2 2013 and has held it in 53 quarters since. The position peaked at $8.45M in Q1 2015. 1,038 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.
- Ameritas Investment Partners held 1,262 shares of Biogen worth $273K as of Q2 2026.
- Ameritas Investment Partners sold 74 Biogen shares in Q2 2026, an estimated $14.2K.
- Biogen made up 0.01% of Ameritas Investment Partners's portfolio in Q2 2026, its #1209 holding.
- Ameritas Investment Partners first reported a position in Biogen in Q2 2013 and has held it in 53 quarters since.
- Ameritas Investment Partners's Biogen position peaked at $8.45M in Q1 2015.
- 1,038 funds tracked by Wall St. Rank held Biogen as of Q2 2026.
Based on Ameritas Investment Partners's 13F filing for Q2 2026, filed 13 Aug 2026.